[ Price : $8.95]
Federal Register Notice: FDA plans a public workshop 10/17 on changing regulatory and reimbursement paradigms for medical devices ...[ Price : $8.95]
FDA issues Delcath Systems a complete response letter for an NDA for its Melblez Kit (melphalan) for injection for use with the De...[ Price : $8.95]
Ge Pharma recalls Creafuse Powder Grape (Lot# GE4568) and Creafuse Powder Fruit Punch (Lot #GE4570) because they contain an undecl...[ Price : $8.95]
CDER says it has identified a potential safety issue with Astellas Lexiscan (regadenoson) an increased risk of myocardial infarct...[ Price : $8.95]
FDA grants Synta Pharmaceuticals a fast track designation for ganetespib, a heat shock protein 90 (Hsp90) inhibitor drug candidate...[ Price : $8.95]
FDA issues a draft guidance on developing bioanalytical method validation information for human and animal drugs.[ Price : $8.95]
Bristol-Myers Squibb says a Phase 3 trial of its Yervoy in treating advanced prostate cancer failed to meet its primary endpoint o...[ Price : $8.95]
United Therapeutics resubmits an NDA for treprostinil diolamine extended release tablets for treating pulmonary arterial hypertens...